Zacks Investment Ideas feature highlights: Nu Skin Enterprises, Encore Wire, Natus Medical and Gentex

Zacks

For Immediate Release

Chicago, IL- November 5, 2013 – Today, Zacks Investment Ideas feature highlights Features: Nu Skin Enterprises (NUS-Free Report), Encore Wire (WIRE-Free Report), Natus Medical (BABY-Free Report) and Gentex (GNTX-Free Report).

4 Big Winners from Q3 Earnings Season

We are well past the halfway mark for third quarter earnings season with results in from 73% of companies in the S&P 500. Overall, it has been a decent quarter. A solid 67% of companies have beaten earnings with a median surprise of 2.6%, and earnings growth is up 4.3% year-over-year.

More than anything though, the healthy beat ratio this quarter is a testament to managements' ability to "under promise and over deliver". Earnings estimates came down considerably in the months leading up to Q3 earnings season, so it shouldn't be a big surprise that companies can step over the low hurdle they set for themselves.

While earnings surprises may garner most of the attention, I'm much more impressed by a company that beats on both the bottom line and the top line. That's because earnings can often be "massaged" by management to come in a penny or two ahead of consensus. But revenue is generally much less susceptible (although not immune) to manipulation.

So far in Q3, just 53% of companies have beaten expectations on the top-line, while revenue is up 2.8% year-over-year. But this isn't alarming - soft revenues have been a recurring theme in recent quarters.
The Triple Play

Positive revenue and earnings surprises are great, but if management guidance is weak and/or if analysts still revise their earnings estimates lower, a stock can still get punished. The true winners from earnings season are those who can deliver the coveted "Triple Play":
  • A positive earnings surprise
  • A positive revenue surprise, and
  • Significant positive earnings estimate revisions
And as the well-documented "post-earnings announcement drift" shows, these blow out quarters are often handsomely rewarded by the market for several weeks after a company reports.
4 Triple Plays

So which companies have delivered the "Triple Play" this earnings season? I ran a screen in Research Wizard, and here are 4 of the top companies from the list:

Nu Skin Enterprises (NUS-Free Report)

EPS Surprise: +27%
Revenue Surprise: +14%
4-Week Change in 2013 Consensus: +13%
4-Week Change in 2014 Consensus: +16%
Nu Skin Enterprises is a global direct selling company that develops and distributes personal care products and nutritional supplements around the globe. The company delivered a solid "beat and raise" quarter on October 22, prompting a flurry of positive estimate revisions from analysts. It is a Zacks Rank #1 (Strong Buy) stock.

Encore Wire (WIRE-Free Report)

EPS Surprise: +47%
Revenue Surprise: +6%
4-Week Change in 2013 Consensus: +13%
4-Week Change in 2014 Consensus: +13%
Encore Wire manufactures copper electrical wire and cable for residential and commercial use. The company reported significantly better-than-expected third quarter earnings on October 24 and is a Zacks Rank #1 (Strong Buy) stock.

Natus Medical (BABY-Free Report)

EPS Surprise: +58%
Revenue Surprise: +6%
4-Week Change in 2013 Consensus: +23%
4-Week Change in 2014 Consensus: +20%

Natus Medical provides healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. The company reported its 4th consecutive double-digit positive earnings surprise on October 24. It is a Zacks Rank #1 (Strong Buy) stock.

Gentex (GNTX-Free Report)

EPS Surprise: +15%
Revenue Surprise: +4%
4-Week Change in 2013 Consensus: +12%
4-Week Change in 2014 Consensus: +24%

Gentex is an automotive supplier that makes automatic-dimming rearview mirrors and camera-based lighting-assist and driver-assist systems. Analysts revised their estimates significantly higher for Gentex after it delivered its 5th consecutive earnings beat on October 22. It is a Zacks Rank #1 (Strong Buy) stock.

The Bottom Line

Overall, third quarter earnings season has been decent so far. But these four companies each delivered outstanding results and are well-positioned to run higher over the coming weeks.

 About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Click here for your free subscription to Profit from the Pros.
 
Get the full Report on NUS – FREE
Get the full Report on WIRE – FREE
Get the full Report on BABY – FREE
Get the full Report on GNTX – FREE
 
Follow us on Twitter:  http://twitter.com/ZacksResearch
 
Join us on Facebook:  http://www.facebook.com/ZacksInvestmentResearch
 
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
 
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
 
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Read the analyst report on NUS

Read the analyst report on WIRE

Read the analyst report on BABY

Read the analyst report on GNTX


Zacks Investment Research

View Comments (0)